Skip to content
★ Sign in to follow
NS

Neil Solomons

Aurinia Pharmaceuticals Inc.
Total declarations
42
Company
1
▲ Purchases (5 ops.)
€1.3M
▼ Sales (31 ops.)
€13.1M

Latest filing published 07 Mar 2022 for Aurinia Pharmaceuticals Inc..

Filing timeline

BuySale
Neil Solomons

Insider track record

Disclosed buys
5
Disclosed sells
31
Signal history

Neil Solomons: trading record in brief

Neil Solomons discloses dealings in Aurinia Pharmaceuticals Inc. to SEC (Form 4). The record holds 42 filings, for trades running from 23 October 2013 to 2 March 2022.

The open-market side counts 5 purchases for €1.3M alongside 31 sales for €13.1M. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 option exercises.

Half of the purchases are above €294k and half below.

On 7 March 2022 came the latest disclosure, an option exercise in Aurinia Pharmaceuticals Inc. The most recent open-market purchase was published on 12 November 2021, 1,823 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Neil Solomons

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations42 total

25 of 42 declarations